GlassScriptPhysician profile
Christie S Stemmle
NPI 1265540058
$3,627.52
in general payments reported to CMS, 2019-2025
10 companies · $549 in 2025
The $549 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $77.84 · 2021: $132 · 2022: $1,782 · 2023: $292 · 2024: $495 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,336.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,538.54 | 2020-2022 | |
| Alcon Vision LLC | $982.57 | 2020-2025 | Clareon, Precision7, Dailies Total1 |
| Mallinckrodt Hospital Products INC. | $498.32 | 2021-2024 | Acthar |
| Bausch & Lomb Americas INC. | $235.66 | 2022-2025 | Infuse |
| Allergan, INC. | $179.20 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Mallinckrodt Enterprises LLC | $20.65 | 2019 | |
| Dompe US, INC. | $18.75 | 2023 | Oxervate |
| Sun Pharmaceutical Industries INC. | $16.40 | 2019 | |
| Abb Con-Cise Optical Group LLC | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christie Stemmle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.